$ARX

RADKE JEFFREY L sold $1.4M of ARX (indirect holdings)

RADKE JEFFREY L (Co-Founder, CEO) sold 95,223 indirectly-held shares of Accelerant Holdings (ARX) at an average of $14.60 ($14.45–$14.63, $1.39M total) across 2 trades on 2026-07-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · RADKE JEFFREY L
Published Jul 29, 2026, 1:25 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 1:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ARX
Neutral
medium confidence
Mentioned
$ARX
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARXNeutralLow
01

Why it matters

Traders may monitor for follow-on insider activity or changes in ownership patterns, but the 10b5-1 designation generally reduces interpretive weight.

02

Market read

A $1.39M insider sale in ARX under a 10b5-1 plan is disclosed, offering limited incremental signal absent other catalysts.

03

What to watch

The article does not disclose whether other insiders sold/bought around the same time, nor does it provide post-sale performance context, limiting inference from the transaction alone.

Relevance 5/10Novelty 5/10Timing: SEC Form 4 filed 2026-07-28 for sales executed 2026-07-27.

Background

The article is an SEC Form 4 insider transaction for Accelerant Holdings (ARX) by co-founder/CEO RADKE JEFFREY L, with the sale executed on 2026-07-27 and filed on 2026-07-28.

Company-level read

Ticker impact

$ARXNeutralMedium confidence
Context

Form 4 shows co-founder/CEO RADKE JEFFREY L sold 95,223 shares of Accelerant Holdings (ARX) for about $1.39M under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived unless paired with other company-specific news.

Evidence & confidence

The filing is a primary SEC Form 4 disclosure with defined trade dates, prices, and 10b5-1 pre-arrangement, reducing the probability that the sale reflects new negative information.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • Accelerant Holdings

    Company whose shares were sold by an insider under a 10b5-1 plan.

  • RADKE JEFFREY L

    Co-Founder, CEO, and 10% owner who executed the open-market sale.

Related articles

$ARXMed

ARX: Q2 2026 delivered robust operational and financial results, with the Shell acquisition progressing

Less than 1 min read Q2 2026 saw strong production growth and higher realized prices, driving a 20% year-over-year increase in funds from operations and a 94% rise in free funds flow per share. Net income declined 9% per share due to lower risk management gains and higher costs. The pending $22 billion Shell acquisition remains on track. Original document: ARC Resources Ltd. [ARX] Interim report — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies.

$ARXMed

ARX: Q2 2026 delivered robust production and cash flow as the $22B Shell acquisition advances

Less than 1 min read Q2 2026 saw 9% year-over-year production growth and strong cash flow, with $816 million in funds from operations and $349 million in free funds flow. The $22 billion Shell acquisition is progressing, with closing expected in Q3 2026. Original document: ARC Resources Ltd. [ARX] Earnings Release — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

$ARXMed

Accelerant Holdings Stock Rises 10%

Accelerant Holdings (ARX) shares rose 9.73% to $12.86 on Wednesday after the company said it expanded a partnership with Incline P&C Group. Effective July 1, 2026, Incline will act as a fronting carrier for over $500 million in annual gross written premiums across Accelerant’s U.S. commercial specialty insurance portfolio.

$ARXMedAI 8/10

Oil Volatility Is Back: 3 Canadian Stocks to Buy Now

The article says oil and gas prices remain volatile and highlights three Canadian energy stocks. Tourmaline Oil (TOU) reported record Q1 production and expects higher free cash flow in 2026-27, planning a $0.50 quarterly base dividend (yield ~3.1%). Birchcliff (BIR) reported strong Q1 2026 results and a $0.03 quarterly dividend. ARC Resources (ARX) reported Q1 2026 net income of $584m ($1.03/share) and agreed to be acquired by Shell in a ~$16.4bn deal including debt.